{
    "clinical_study": {
        "@rank": "57094", 
        "arm_group": {
            "arm_group_label": "Ringer`s lactate", 
            "arm_group_type": "Experimental", 
            "description": "Fluid therapy during operation"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate the effect of thin fluid with starch versus thin\n      fluid without starch on coagulation in elective surgery when the patient is normovol\u00e6mic\n      during operation."
        }, 
        "brief_title": "Effect of Colloid Versus Crystalloid on Coagulation in Elective Urological Surgery", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Disorders of Coagulation", 
        "condition_browse": {
            "mesh_term": [
                "Blood Coagulation Disorders", 
                "Hemostatic Disorders"
            ]
        }, 
        "detailed_description": {
            "textblock": "The primary goal is to register coagulation on basis of blood samples inclusive\n      thromboelastography results.\n\n      The secondary goal is to register blood loss and use of blood products during operation.\n\n      The trial concerns 40 patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient older than 18 years.\n\n          -  Indication for elective surgery with removal of the urine bladder.\n\n          -  Patient without anticoagulative, acethylsalisylsyre or NSAID medicine during the last\n             5 days,if using.\n\n        Exclusion Criteria:\n\n          -  Cerebral haemorrhage\n\n          -  Renal insufficiency demanding dialysis\n\n          -  Manifest cardiac and hepatic insufficiency\n\n          -  Disturbance in coagulation\n\n          -  Hypernatri\u00e6mi\n\n          -  Hyperchlor\u00e6mi\n\n          -  Pregnant or nursing\n\n          -  Allergic to hydroxyethylstarch\n\n          -  Participating in another trial-if interferring the present trial\n\n          -  Incapable of managing his own affairs."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 18, 2011", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02009033", 
            "org_study_id": "H-2-2011-063"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ringer`s lactate", 
                "description": "When normovol\u00e6mic status of the patient is secured, 35 ml/kg of the allocated fluid is infused during the operation (estimated time for this type of operation is 180 minutes), however max. 3500 ml.Lactated Ringer is the interventional medication.", 
                "intervention_name": "Lactated Ringer", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Ringer`s lactate", 
                "intervention_name": "Hydroxyethylstarch", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Hetastarch"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 6, 2013", 
        "number_of_arms": "1", 
        "official_title": "Effect of Colloid Versus Crystalloid on Coagulation in Elective Urological Surgery. A Randomised Clinical Study", 
        "overall_official": {
            "affiliation": "Rigshospitalet , Dept. 2042, 2100 Copenhagen", 
            "last_name": "Niels Henry Secher, Professor", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Denmark: Danish Medicines Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Estimate coagulation on basis of bloodsamples", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02009033"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rigshospitalet, Denmark", 
            "investigator_full_name": "K. C. Rasmussen", 
            "investigator_title": "MD", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Estimate coagulation by bloodloss and need for transfusion", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "Rigshospitalet, Denmark", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "K. C. Rasmussen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}